Literature DB >> 21357941

Gastrointestinal polyps in McCune Albright syndrome.

Margaret Zacharin1, Anurag Bajpai, Chung Wo Chow, Anthony Catto-Smith, Constantine Stratakis, Michelle W Wong, Rodney Scott.   

Abstract

BACKGROUND: McCune Albright syndrome (MAS), a disorder caused by somatic activating mutations in the GNAS gene, usually presents with cutaneous, skeletal, and endocrine manifestations. While focal lesions involving multiple tissues have been identified in MAS, almost nothing is known about gastrointestinal lesions in this disease.
METHODS: Two MAS patients with perioral freckling, resembling Peutz-Jeghers syndrome (PJS), and two MAS patients without similar pigmentation underwent gastrointestinal endoscopy to establish if they had coexisting hamartomatous polyposis. Three of 4 subjects had documented GNAS mutations in peripheral blood. Genetic testing for STK11 and PRKAR1A genes was performed to exclude presence of coexistent PJS and Carney complex. Genetic testing of biopsy material was also performed.
RESULTS: Hamartomatous gastrointestinal polyps with histological features similar to those in PJS were observed in all 4 subjects, only in the stomach and/or upper duodenum. Activating GNAS mutations were found in the polyps or adjacent mucosa in 3 of 4 subjects. One patient each had mutation only in the blood or tissue, while 2 patients had both. No subject harboured any detectable PRKARIA or STK11 mutation as determined by direct DNA sequencing and copy number variation analysis.
CONCLUSIONS: These findings confirm that gastrointestinal polyps are a common manifestation of MAS, indicate an overlap between MAS and PJS, and point towards a putative interaction between the GNAS and STK11 genes in the pathogenesis of these two disorders. The findings suggest a need for routine gastrointestinal endoscopy in patients with MAS, to establish the true incidence of polyps in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357941      PMCID: PMC4034052          DOI: 10.1136/jmg.2010.086330

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report.

Authors:  G Mastorakos; N S Mitsiades; A G Doufas; D A Koutras
Journal:  Thyroid       Date:  1997-06       Impact factor: 6.568

2.  Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene.

Authors:  Maria Candida Barisson Villares Fragoso; Sorahia Domenice; Ana Claudia Latronico; Regina Matsunaga Martin; Maria Adelaide Albergaria Pereira; Maria Claudia Nogueira Zerbini; Antonio Marmo Lucon; Berenice Bilharinho Mendonca
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

3.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

4.  Albright's syndrome--thirty years later. (Polyostotic fibrous dysplasia).

Authors:  H E MacMahon
Journal:  Pathol Annu       Date:  1971

5.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

6.  Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males.

Authors:  Malgorzata Wasniewska; Filippo De Luca; Silvano Bertelloni; Patrizia Matarazzo; Giovanna Weber; Giuseppe Crisafulli; Mariella Valenzise; Roberto Lala
Journal:  J Pediatr       Date:  2004-11       Impact factor: 4.406

7.  Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone.

Authors:  G A Candeliere; P J Roughley; F H Glorieux
Journal:  Bone       Date:  1997-08       Impact factor: 4.398

8.  McCune-Albright syndrome associated with pituitary microadenoma: patient report.

Authors:  Chun-Jung Chen; Jah-Yao Liu; Shin-Nan Cheng; Fung-Wei Chang; Yeong-Seng Yuh
Journal:  J Pediatr Endocrinol Metab       Date:  2004-03       Impact factor: 1.634

9.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

10.  An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.

Authors:  C D Malchoff; G Reardon; D C MacGillivray; H Yamase; A D Rogol; D M Malchoff
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

View more
  10 in total

1.  Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas.

Authors:  Laura D Wood; Michaël Noë; Wenzel Hackeng; Lodewijk A A Brosens; Feriyl Bhaijee; Marija Debeljak; Jun Yu; Masaya Suenaga; Aatur D Singhi; Atif Zaheer; Alison Boyce; Cemre Robinson; James R Eshleman; Michael G Goggins; Ralph H Hruban; Michael T Collins; Anne Marie Lennon; Elizabeth A Montgomery
Journal:  Virchows Arch       Date:  2017-02-10       Impact factor: 4.064

2.  Oral pigmentation in McCune-Albright syndrome.

Authors:  Dominique C Pichard; Alison M Boyce; Michael T Collins; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

3.  Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome.

Authors:  Cemre Robinson; Andrea Estrada; Atif Zaheer; Vikesh K Singh; Christopher L Wolfgang; Michael G Goggins; Ralph H Hruban; Laura D Wood; Michaël Noë; Elizabeth A Montgomery; Lori C Guthrie; Anne Marie Lennon; Alison M Boyce; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  GNAS is not involved in gastrointestinal tumour formation in Peutz-Jeghers syndrome.

Authors:  Susanne E Korsse; Maikel P Peppelenbosch; Ron Smits; Wendy van Veelen
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 5.  The Clinical Spectrum of McCune-Albright Syndrome and Its Management.

Authors:  Tiahna Spencer; Kristen S Pan; Michael T Collins; Alison M Boyce
Journal:  Horm Res Paediatr       Date:  2019-12-19       Impact factor: 2.852

Review 6.  Gastric Hamartomatous Polyps-Review and Update.

Authors:  Monika Vyas; Xiu Yang; Xuchen Zhang
Journal:  Clin Med Insights Gastroenterol       Date:  2016-04-07

Review 7.  Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Authors:  Muhammad Kassim Javaid; Alison Boyce; Natasha Appelman-Dijkstra; Juling Ong; Patrizia Defabianis; Amaka Offiah; Paul Arundel; Nick Shaw; Valter Dal Pos; Ann Underhil; Deanna Portero; Lisa Heral; Anne-Marie Heegaard; Laura Masi; Fergal Monsell; Robert Stanton; Pieter Durk Sander Dijkstra; Maria Luisa Brandi; Roland Chapurlat; Neveen Agnes Therese Hamdy; Michael Terrence Collins
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

8.  The curious case of Gαs gain-of-function in neoplasia.

Authors:  Giulio Innamorati; Thomas M Wilkie; Havish S Kantheti; Maria Teresa Valenti; Luca Dalle Carbonare; Luca Giacomello; Marco Parenti; Davide Melisi; Claudio Bassi
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

Review 9.  Auxological and Endocrinological Features in Children With McCune Albright Syndrome: A Review.

Authors:  Maria Tufano; Daniele Ciofi; Antonella Amendolea; Stefano Stagi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-04       Impact factor: 5.555

Review 10.  Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Authors:  Alison M Boyce; Michael T Collins
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.